Comparison of radiofrequency and microwave ablation and identification of risk factors for primary treatment failure and local progression

To compare percutaneous radiofrequency ablation (RFA) and microwave ablation (MWA) for treatment of Hepatocellular carcinoma (HCC) and to identify risk factors for treatment failure and local progression.

Source: Clinical Imaging - June 18, 2020 Category: Radiology Authors: Joseph L. McDevitt, Michael D. Collard, Ryan P. Murphy, Patrick D. Sutphin, Adam C. Yopp, Amit G. Singal, Sanjeeva P. Kalva Tags: Vascular and Interventional Radiology Source Type: research